Bellevue Life Sciences Acquisition Corp.
BLAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $52 | $81 | $91 | $80 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $0 | $1 | $0 |
| Enterprise Value | $53 | $81 | $93 | $80 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | $4 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$2 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.54 | 0.072 | -0.004 | -0 |
| % Growth | -852.1% | 1,941% | -875% | – |
| Operating Cash Flow | -$2 | -$1 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | -$0 | -$0 |